Bruno Bonamichi Bueno

Bruno Bonamichi Bueno has a diverse range of work experience in the field of intellectual property and consultancy.

From 2011 to 2016, they worked at Ourofino Animal Health, where they served as an Intellectual Property Assistant, assisting in the management of the company's industrial property portfolio. Bruno also performed various studies using patent information and participated in innovation committees and technical groups within the R&D team. Additionally, as a Research and Development Assistant, Bruno developed pharmaceutical formulations in a laboratory setting.

Starting in 2016, Bruno joined Ache Pharmaceutical Laboratories as an Intellectual Property Coordinator. In this role, they coordinated the portfolio of patents and patent applications for the company in Brazil and abroad. Bruno provided support to PD&I teams in developing appropriate strategies for protecting intellectual property assets of innovative projects. Bruno was responsible for preparing, drafting, and filing patent applications, utility models, and industrial design registrations in the pharmaceutical field. Later on, they transitioned to the role of Sr. Patent Analyst within the Radical Innovation Department, where they provided information based on patent documents to support decision-making in the development of pharmaceutical and portfolio complementation projects.

In 2022, Bruno joined Bonamichi & Bueno Consultoria LTDA as a Consultant in Industrial Property. Bruno'sresponsibilities in this role include providing consultancy services related to industrial property matters.

Most recently, in 2023, Bruno started working at CAS as a Customer Success Manager.

Bruno Bonamichi Bueno completed their education in a chronological manner. Bruno first attended Centro Universitário Newton Paiva from 2005 to 2010, where they obtained a Bachelor's degree in Pharmacy. After that, they pursued a Master's degree in Applied Biociences to Pharmacy at the University of São Paulo (USP), from 2013 to 2016. Lastly, in 2023 and 2024, Bruno pursued a Postgraduate degree in Biodiversity Medicines Innovation at FIOCRUZ - Fundação Oswaldo Cruz.